Gland Pharma Limited IPO Message Board (Page 26)

Company's book value and EPS as on 31.03.2020 are 49.88 and 235.32.
Asking a PE ratio is 30.07 and PB ratio is 6.37 .

Although there is no listed peers for the company, let's look at the P/Es of some of the reputed pharma companies

Company EPS(as on 31.03.2020) CMP P/E
Dr lal pathlab 27.42 2300 83.88
Sun Pharma 15.70 515 32.80
Dr Reddys 121.99 4939 40.49

So, I do not find asking P/E 30 expensive for Gland Pharma. I am doing this analysis first time and so please check it. If I have perform some mistake, please correct it.

If price band is really @ 1500, I will avoid after seeing the condition of recent IPOs which had not performed even after very high subscription. After 2 initial IPOs, not much to cheer about.

Trump is going to be the second term USA president

Dear foram members which application can be use for get live grey premium

No application for live premium update.
Only know from broker

Thanks bro for your kind reply

Aniket IAF Ji

Your views / Opinion on Gland Pharma.. ????

Alright..

Aap kitna price band ko acha maanonge ?

As strong rumours of price band at very high rate.. ????

As expected..

Price Band is Too High at 1500, nothing much on table..

Gmp also crashed to 100 level..

Your final take Aniket Ji..

@SatishKumarIPO! Kostak is the estimated price per share @ which the IPO application is available for sale. The buyer needs to take risk and bear the profit or loss after he invests his own money for applying to the IPO in addition to the Kostak price he pays to the seller.

gmp 115

Gmp 80 90

Gland Pharma IPO

GMP 105 +/- 2
Kostak 650 +/- 25

Gland Pharma IPO

GMP 115 +/- 2
Kostak 725 +/- 25

Simply avoid two reasons
1. High price band
2.china

hello ankitiaf sir what is your opinion for gland pharma gmp and good ipo or not?

Gland Pharma Ltd IPO

Opens : 9th Nov 2020
Closes : 11th Nov 2020
Price Band : Rs 1490-Rs 1500
Lot : 10 shares

Gland Pharma IPO – Financial Information (Basis of Valuation)
The information is collated from the following documents:
1) RHP = Red Herring Prospectus dated October 31, 2020 (333 pages)

EPS for FY17-18 >>> Rs.20.72 (Page #86 of RHP)
EPS for FY18-19 >>> Rs.29.16 (Page #86 of RHP)
EPS for FY19-20 >>> Rs.49.88 (Page #86 of RHP)
EPS for Q120-21 >>> Rs.20.24 (Page #86 of RHP)

RoNW for FY17-18 >>> 13.32% (Page #87 of RHP)
RoNW for FY18-19 >>> 15.79% (Page #87 of RHP)
RoNW for FY19-20 >>> 21.20% (Page #87 of RHP)
RoNW for Q120-21 >>> 07.91% (Page #87 of RHP)

NAV as on June 30, 2020 was Rs.255.79 (Page #87 of RHP)

Listed Industry Peer Group (Page #87 of DRHP): NONE

Gland Pharma IPO

TODAY'S TARGET

GMP 100 +/- 2
Kostak 625 +/- 25

Subscription required for 1X

RII = 15,11,894 Forms

NII = 971.93 Crs

Price band is too much high..
I think wait and watch for last day..
Very risky now..

Gland Pharma IPO

GMP 135 +/- 2
Kostak 850 +/- 25

Gland Pharma IPO – Issue Information *(FINAL)*

Issue Opens on: 09 November 2020
Issue Closes on: 11 November 2020
Issue Type: Book Built Issue IPO
Issue Size: 4,31,96,968 Shares
Face Value: Rs.1/- per Share
Issue Price: Rs.1,490 – Rs.1,500 per Share *(FINAL)*
Discount: NIL
Market Lot: 10 Shares
Listing At: NSE, BSE

Equity Shares outstanding prior to the Issue = 15,49,49,490 Shares
Fresh Issue of Shares 83,33,333 @1,500/- = Rs.1,250.00Crs
Offer for Sale of 3,48,63,635 Shares @1,500/- = Rs.5,229,55Crs
Equity Shares outstanding after the Issue = 16,32,82,823 Shares

Category-wise Break up:
Anchor – 1,29,59,090 Shares = 1,943.86Crs
QIB – 86,39,394 Shares = 1,295.91Crs
NII – 64,79,545 Shares = 971.93Crs
RII – 1,51,18,939 Shares = 2,267.84Crs (Lot size:10 = 15,11,894 Forms)
Total Issue – 4,31,96,968 Shares = 6,479.55Crs.

Subscription required for 1X
RII = 15,11,894 Forms
NII = 971.93 Crs

Gland

Price band 1490-1500
Lot 10